Advertisement
Advertisement
Trending on Dermatology Times
1
Abeona Initiates First Commercial Treatment of Zevaskyn for RDEB
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Enhancing Biologic Use in Hidradenitis Suppurativa
4
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
5
